David Q.‐H. Wang

11.5k total citations · 3 hit papers
145 papers, 8.3k citations indexed

About

David Q.‐H. Wang is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, David Q.‐H. Wang has authored 145 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Surgery, 76 papers in Oncology and 42 papers in Epidemiology. Recurrent topics in David Q.‐H. Wang's work include Drug Transport and Resistance Mechanisms (73 papers), Cholesterol and Lipid Metabolism (45 papers) and Liver Disease Diagnosis and Treatment (38 papers). David Q.‐H. Wang is often cited by papers focused on Drug Transport and Resistance Mechanisms (73 papers), Cholesterol and Lipid Metabolism (45 papers) and Liver Disease Diagnosis and Treatment (38 papers). David Q.‐H. Wang collaborates with scholars based in United States, Italy and Germany. David Q.‐H. Wang's co-authors include Piero Portincasa, Martin C. Carey, Agostino Di Ciaula, Leonilde Bonfrate, Helen H. Wang, Gabriella Garruti, Min Liu, Frank Lammert, Helen H. Wang and David E. Cohen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

David Q.‐H. Wang

143 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis

2022 581 citations Piero Portincasa, Leonilde Bonfrate et al. International Journal of Molecular Sciences profile →
Gallstones

2016 499 citations Piero Portincasa, Karel J. van Erpecum et al. profile →
Bile Acid Physiology

2017 389 citations Agostino Di Ciaula, Gabriella Garruti et al. profile →

Peers

Countries citing papers authored by David Q.‐H. Wang

Since Specialization

Citations

This map shows the geographic impact of David Q.‐H. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Q.‐H. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Q.‐H. Wang more than expected).

Fields of papers citing papers by David Q.‐H. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Q.‐H. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Q.‐H. Wang. The network helps show where David Q.‐H. Wang may publish in the future.

Co-authorship network of co-authors of David Q.‐H. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of David Q.‐H. Wang. A scholar is included among the top collaborators of David Q.‐H. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Q.‐H. Wang. David Q.‐H. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis breakdown → 2022 ·International Journal of Molecular Sciences ·Piero Portincasa, Leonilde Bonfrate, Mirco Vacca, Maria De Angelis, Ilaria Farella, Elisa Lanza, Mohamad Khalil, David Q.‐H. Wang, Markus Sperandio, Agostino Di Ciaula	581
2	Intestinal Barrier and Permeability in Health, Obesity and NAFLD 2021 ·Biomedicines ·Piero Portincasa, Leonilde Bonfrate, Mohamad Khalil, Maria De Angelis, Francesco Maria Calabrese, Mauro D’Amato, David Q.‐H. Wang, Agostino Di Ciaula	149
3	Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease 2021 ·Molecular Metabolism ·Yanyong Xu, Yingdong Zhu, Shuwei Hu, Xiaoli Pan, (unknown), Helen H. Wang, David Q.‐H. Wang, Liya Yin, Yanqiao Zhang	56
4	Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk 2020 ·Journal of Clinical Medicine ·Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q.‐H. Wang, Piero Portincasa	109
5	Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome 2020 ·Nutrients ·Piero Portincasa, Agostino Di Ciaula, Gabriella Garruti, Mirco Vacca, Maria De Angelis, David Q.‐H. Wang	40
6	Regulation of Cholesterol Metabolism by Bioactive Components of Soy Proteins: Novel Translational Evidence 2020 ·International Journal of Molecular Sciences ·Giusy Rita Caponio, David Q.‐H. Wang, Agostino Di Ciaula, Maria De Angelis, Piero Portincasa	33
7	Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3 2020 ·Journal of Hepatology ·Guangyan Wei, Jingsong Cao, Pinzhu Huang, Ping An, (unknown), Kahini A. Vaid, Shuangshuang Zhao, David Q.‐H. Wang, (unknown), Ling Yin, Andrea Frassetto, (unknown), Vladimir Presnyak, Srujan Gandham, Serenus Hua, Christine Lukacs, Patrick F. Finn, Paloma H. Giangrande, Paolo G.V. Martini, Yury Popov	48
8	Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease 2017 ·European Journal of Clinical Investigation ·Helen H. Wang, Min Liu, Xiaodan Li, Piero Portincasa, David Q.‐H. Wang	13
9	An update on the pathogenesis of cholesterol gallstone disease 2017 ·Current Opinion in Gastroenterology ·Agostino Di Ciaula, David Q.‐H. Wang, Piero Portincasa	172
10	New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile 2017 ·Liver Research ·Helen H. Wang, Tiangang Li, Piero Portincasa, David A. Ford, Brent A. Neuschwander‐Tetri, Patrick Tso, David Q.‐H. Wang	21
11	New Exploration of Chinese Herbal Medicines in Hepatology 2016 ·Evidence-based Complementary and Alternative Medicine ·Yibin Feng, Man‐Fung Yuen, Qihe Xu, Xiao‐Yan Wen, David Q.‐H. Wang	1
12	Apolipoprotein A-V is present in bile and its secretion increases with lipid absorption in Sprague-Dawley rats 2015 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Linda Zhang, Hirokazu Sato, Qing Yang, Robert O. Ryan, David Q.‐H. Wang, Philip N. Howles, Patrick Tso	9
13	Ezetimibe prevents the formation of oestrogen‐induced cholesterol gallstones in mice 2014 ·European Journal of Clinical Investigation ·Ornella de Bari, Helen H. Wang, Piero Portincasa, Chang Nyol Paik, Min Liu, David Q.‐H. Wang	7
14	Biochemical mechanisms in drug-induced liver injury: Certainties and doubts 2009 ·World Journal of Gastroenterology ·Ignazio Grattagliano, Leonilde Bonfrate, Cátia V. Diogo, Helen H. Wang, David Q.‐H. Wang, Piero Portincasa	109
15	Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Helen H. Wang, Piero Portincasa, Min Liu, Patrick Tso, Linda C. Samuelson, David Q.‐H. Wang	42
16	Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function 2005 ·Journal of Lipid Research ·Karel J. van Erpecum, David Q.‐H. Wang, Antonio Moschetta, Domenico Ferri, Maria Svelto, Piero Portincasa, Jan Hendrickx, M.E.I. Schipper, Giuseppe Calamita	83
17	Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis 2004 ·Journal of Clinical Investigation ·David Q.‐H. Wang, Frank Schmitz, Alan S. Kopin, Martin C. Carey	73
18	Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis 2004 ·Journal of Clinical Investigation ·David Q.‐H. Wang, Frank Schmitz, Alan S. Kopin, Martin C. Carey	8
19	Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice 2004 ·Journal of Lipid Research ·(unknown), Helen H. Wang, David Q.‐H. Wang	84
20	Cryoelectron Microscopy of a Nucleating Model Bile in Vitreous Ice: Formation of Primordial Vesicles 1999 ·Biophysical Journal ·Donald Gantz, David Q.‐H. Wang, (unknown), Donald Small	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact